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Escherichia coli is a common commensal bacterial species of humans and animals that
may become a troublesome pathogen causing serious diseases. The aim of this study
was to characterize the quinolone resistance phenotypes and genotypes in E. coli isolates
of different origin from one area of the Czech Republic. E. coli isolates were obtained from
hospitalized patients and outpatients, chicken farms, retailed turkeys, rooks wintering
in the area, and wastewaters. Susceptibility of the isolates grown on the MacConkey
agar with ciprofloxacin (0.05 mg/L) to 23 antimicrobial agents was determined. The
presence of plasmid-mediated quinolone resistance (PMQR) and ESBL genes was
tested by PCR and sequencing. Specific mutations in gyrA, gyrB, parC, and parE were
also examined. Multilocus sequence typing and pulsed-field gel electrophoresis were
performed to assess the clonal relationship. In total, 1050 E. coli isolates were obtained,
including 303 isolates from humans, 156 from chickens, 105 from turkeys, 114 from the
rooks, and 372 from wastewater samples. PMQR genes were detected in 262 (25%)
isolates. The highest occurrence was observed in isolates from retailed turkey (49% of
the isolates were positive) and inpatients (32%). The qnrS1 gene was the most common
PMQR determinant identified in 146 (56%) followed by aac(6′)-Ib-cr in 77 (29%), qnrB19
in 41 (16%), and qnrB1 in 9 (3%) isolates. All isolates with high level of ciprofloxacin
resistance (>32 mg/L) carried double or triple mutations in gyrA combined with single or
double mutations in parC. The most frequently identified substitutions were Ser(83)Leu;
Asp(87)Asn in GyrA, together with Ser(80)Ile, or Glu(84)Val in ParC. Majority of these
isolates showed resistance to beta-lactams and multiresistance phenotype was found
in 95% isolates. Forty-eight different sequence types among 144 isolates analyzed were
found, including five major clones ST131 (26), ST355 (19), ST48 (13), ST95 (10), and
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ST10 (5). No isolates sharing 100% relatedness and originating from different areas
were identified. In conclusion, our study identified PMQR genes in E. coli isolates in all
areas studied, including highly virulent multiresistant clones such as ST131 producing
CTX-M-15 beta-lactamases.
Keywords: Escherichia coli, quinolone resistance, human, animals, wastewater, MLST, PFGE
INTRODUCTION
Escherichia coli is a common part of the gastrointestinal flora
of humans and animals but some strains can cause serious
diseases. Quinolones are the antimicrobial agents of choice for
treatment of various infections caused by E. coli or other Gram-
negative bacteria. Because of extensive use for multiple clinical
indications in human or veterinary medicine, bacterial resistance
to quinolones has developed over the time (Andriole, 2005).
The World Health Organization indicated fluoroquinolones
as critically important drugs for human medicine due to a
strong correlation observed between the consumption and an
increase in the resistance, and they recommended prudent use
of fluoroquinolones both in human and veterinary medicine
(World Health Organization, 2012).
According to the European Antimicrobial Resistance
Surveillance Network (EARS-Net), an interactive database,
an alarming emergence of fluoroquinolone-resistant invasive
E. coli isolates is evident in European countries (European
Centre for Disease Prevention and Control, 2015). Quinolone
antibiotics are one of the most widely used antimicrobial agents
in the treatment of urinary tract infections. Unfortunately, the
extensive use has led to the increase of the rate of E. coli isolates
resistant to fluoroquinolones all over the world (Lautenbach
et al., 2004; Dalhoff, 2012). Resistance to nalidixic acid and
ciprofloxacin was reported as high or extremely high in isolates
from broilers in European countries (ECDC, EFSA, and EMA,
2015). E. coli isolates resistant to fluoroquinolones has been
described in food-producing and companion animals (Platell
et al., 2011; Gosling et al., 2012; Literak et al., 2013; Agabou et al.,
2016) as well as in wild animals and the environment (Jiménez
Gómez et al., 2004; Colomer-Lluch et al., 2013).
Target sites for quinolones in E. coli strains are the bacterial
topoisomerases, namely DNA gyrase (topoisomerase II) as the
primary site and topoisomerase IV as a secondary target. Both
enzymes are essential for bacterial DNA replication. Mutations
in specific domains of gyrA, gyrB, parC, and parE cause
single aminoacid changes in either gyrase or topoisomerase
IV that contribute to quinolone resistance. Multiple mutations
in the quinolone-determining resistant regions (QRDR) of
topoisomerase enzymes are usually associated with high-level
of fluoroquinolone resistance in E. coli strains (Hopkins et al.,
2005). Target-mediated resistance represents the most common
and clinically most significant form (Ruiz, 2003; Aldred et al.,
2014).
The first identified plasmid-mediated quinolone resistance
(PMQR) gene was discovered in 1998 and termed qnrA1
(Martínez-Martínez et al., 1998). So far, three families of plasmid-
mediated mechanisms associated with quinolone resistance
have been identified: i/Qnr proteins protecting target enzymes
DNA gyrase and topoisomerase IV from quinolone inhibition
ii/ aminoglycoside acetyltransferase Aac(6′)-Ib-cr acetylating
several fluoroquinolones such as ciprofloxacin and norfloxacin
and iii/ eﬄux pumps QepA and OqxAB removing antibiotics
from bacterial cells. PMQR provide only a low level of quinolone
resistance, not reaching the clinical breakpoints defined by the
Clinical and Laboratory Standard Institute criteria (CLSI, 2015).
However, PMQR genes may facilitate the selection of higher-level
resistance in the presence of quinolones and lead to treatment
failure (Strahilevitz et al., 2009; Jacoby et al., 2014).
The aims of this study were to determine the occurrence of
PMQR in E. coli isolates from humans, food-producing animals,
wild animals and wastewater samples from one defined area in
the Czech Republic and to compare genetic characteristics of
PMQR-positive E. coli isolates from various sources as well as to
outline possible ways of their transmission between humans and
animals.
MATERIAL AND METHODS
Sample Collection
Between May 2013 and December 2014, E. coli isolates were
obtained from human clinical materials (urine, stool, sputum,
blood, bile, endotracheal aspirate, samples from cannulas,
and bronchoalveolar lavages) of patients hospitalized at the
University Hospital Olomouc (UHO) in the Czech Republic
and from urine samples from outpatients in the community
of Olomouc Region. The community subjects had neither been
hospitalized in the previous 3 months nor had been living in
nursing homes.
In the same period (May 2013 and December 2014), E. coli
isolates were obtained from environmental samples from chicken
farms (n = 2628) and cloacal swabs from market-weight
turkeys at slaughterhouses (n = 120) in the eastern part of
the Czech Republic (Olomouc and South Moravian Region).
Environmental samples were taken from bedding using gauze
shoe covers worn by a worker who walked through a poultry
house. Turkey cloacal swabs were collected at slaughterhouses
and placed into Amies transport medium.
Wastewaters were taken during 2013–2015 in six sampling
sites that included wastewater treatment plants (WWTP) from
four hospitals located in three towns of the Olomouc Region
(Olomouc, Prostejov and Sternberk) (WWTP1-4), the abattoir
in Prerov (WWTP5) and WWTP near Hencˇlov (WWTP6).
In total, 124 wastewater samples were examined including 21
samples from WWTP1 (in 2013-6 samples; 2014-13; 2015-2), 25
from WWTP2 (2014-20, 2015-5), 19 from WWTP3 (in 2013-6;
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2014-11, 2015-2), 19 from WWTP4 (in 2013-6; 2014-11, 2015-
2), 21 from WWTP5 (collected weekly for a period of 4 months
in 2013/2014, plus 3 control samplings were made in May and
August 2014) and 19 fromWWTP6 (collected weekly for a period
of 4 months in 2013/2014). Cellulose swabs were immersed into
wastewater at the inflow and/or outflow of sampling points for 48
h according to the procedure described (Moore et al., 1952).
Faecal rook (Corvus frugilegus) samples (n = 595) were
collected from roosting places used by rook flocks in the
Olomouc Region. The samples were collected in Prerov in
October, November and December 2012, in Tovacov from
January till March 2013, and in Troubky in November
2013. The sampling method has been described previously
(Literak et al., 2012). Smears from fresh feces were taken
by cotton swabs tampons and inserted into Amies transport
medium.
Selective Cultivation of E. coli and
Detection of PMQR Genes
After delivery to the laboratory, collected samples were handled
according to the following procedures in order to isolate E. coli.
Samples from the environment of chicken farms were
placed into peptone water and incubated aerobically for 24 h
at 37◦C. Subsequently, the peptone water was inoculated
onto MacConkey agar with ciprofloxacin (0.05mg/L; MCACIP)
and cultivated overnight. Swabs from retailed turkeys were
subcultivated directly on MCACIP overnight. One isolate per
sample was selected for further phenotypic and genetic analysis.
Swabs taken from wastewaters were inserted into a sterile
bottle with peptone water and incubated at 37◦C for 24 h.
The enriched samples of peptone water were subcultivated
on MCACIP overnight. One to ten colonies of lactose-positive
colonies showing different morphology were taken from each
MCACIP and subjected to further examination.
Faecal swabs from rooks were incubated in buffered peptone
water at 37◦C overnight and subsequently cultivated on MCACIP
overnight. In this type of sample, also only one isolate per sample
was selected.
Human clinical material was handled according to the types
of material and cultivated aerobically for 24 h at 37◦C. A total
number of 3521 E. coli isolates were collected and from these,
three hundred and three isolates were randomly selected for
detection of PMQR genes. The collection analyzed included 270
resistant (MIC of ciprofloxacin>0.5mg/L) and 33 sensitive (MIC
of ciprofloxacin ≤0.5 mg/L) isolates according to the European
Committee in Antimicrobial Susceptibility Testing (EUCAST)
criteria.
The species identification of all isolates was confirmed using
matrix-assisted laser desorption/ionization-time of flight mass
spectrometer (MALDI-TOF MS) (Biotyper Microflex, Bruker
Daltonik GmbH, Bremen, Germany).
Genomic DNA of all E. coli isolates obtained using heat
lysis was used as a template for PCR detection of PMQR genes
(aac(6′)-Ib-cr, qepA, qnrA, qnrB, qnrC, qnrD, qnrS, oqxAB),
followed by sequencing of the amplicons. As positive controls,
well-known characterized strains were included in each reaction
(Table S1).
Antimicrobial Susceptibility Testing of
PMQR-Positive Isolates
For each PMQR-positive E. coli isolate, susceptibilities
to ampicillin (the ranges of tested concentrations for the
antimicrobial substance were 0.5–64 mg/L, ampicillin/sulbactam
(0.5–64), cefazolin (0.5–64), cefuroxime (0.5–64), gentamicin
(0.25–32 or 0.5–64), trimethoprim/sulfamethoxazole (1–128),
colistin (0.25–32), oxolinic acid (0.25–32 or 0.5–64), ofloxacin
(0.125–16 or 0.25–32), tetracycline (0.25–32), aztreonam
(1–64), piperacillin (2–256), piperacillin/tazobactam (2–256),
cefoperazone (0.25–32), cefotaxime (0.125–16), ceftazidime
(0.125–16), cefepime (0.125–16), cefoperazone/sulbactam
(0.5–64), meropenem (0.125–16), ciprofloxacin (0.125–16
or 0.25–32), tigecycline (0.06–8), tobramycin (0.25–32), and
amikacin (0.5–32) were tested using the standard microdilution
method according to the EUCAST (European Committee
on Antimicrobial Susceptibility Testing) breakpoint criteria
(European Centre for Disease Prevention and Control, 2015).
Microdilution antibiotic panels were prepared using dispensing
instrument DYNAMIC 3000 automated system (DYNEX, Czech
Republic). E. coli ATCC 25922 and E. coli ATCC 35218 were
used as reference strains for quality control.
Detection of ESBL Genes in
PMQR-Positive Isolates
All PMQR-positive isolates of E. coli with the minimum
inhibitory concentration (MIC) of the tested 3rd and 4th
generation cephalosporins≥1 mg/L were screened for extended-
spectrum beta-lactamase production (ESBL) using Jarlier’s
double-disk synergy test (DDST) which was modified by
including a disk with cefepime and another disk with ceftazidime
and ceftazidime/clavulanic acid (Jarlier et al., 1988; Htoutou
Sedlakova et al., 2011). Each ESBL-producing isolate was
screened for blaCTX-M, blaTEM and blaSHV genes by PCR followed
by sequencing of amplicons of genes responsible for ESBL
phenotype (Table S1).
Detection of Mutations in the
Topoisomerase Genes and MLST Analysis
of PMQR-Positive Isolates
From a group of 262 PMQR-positive E. coli isolates, 144
isolates from all of the studied areas were selected for further
characterization that included the detection of specific mutations
in gyrA, gyrB, parC and parE genes and multilocus sequence
typing (MLST). Isolates were selected randomly in order to cover
all the studied areas.
Total genomic DNA from E. coli strains was prepared from an
overnight culture (16 h, 37◦C) grown onmeat-peptone agar using
DNeasy Blood & Tissue kit (QIAGEN, Germany) according to
the manufacturer’s recommendations.
PCR amplification of the part of gyrA, gyrB, parC and parE
genes that included the sequence of QRDRs was performed
using previously described primers (Oram and Fisher, 1991;
Vila et al., 1994, 1996; Ruiz et al., 1997). The reaction mixture
contained complete reaction buffer with MgCl2 (containing 100
mmol/L Tris-HCl (pH 8.8), 500 mmol/L KCl, 1% Triton X-100,
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15 mmol/L MgCl2 (Top-Bio, Czech Republic), 0.5 U of Taq
DNA polymerase (Top-Bio), 0.4 µmol/L primer concentration
for each primer, 40 µmol/L concentration of deoxynucleoside
triphosphates and 1 µL of template DNA. The PCR was run
in the Light Cycler96 instrument (Roche, USA) under the
following conditions: initial denaturation at 95◦C for min, 30
cycles of denaturation (95◦C for 30 s), annealing (58◦C for
30 s), extension (72◦C for 60 s), and final extension at 72◦C
for 7min.
MLST of seven housekeeping genes (adk, fumC, gyrB, icd,
mdh, purA, recA) was performed according to theMLST protocol
standardized for E. coli (http://mlst.warwick.ac.uk/mlst/).
For each of the 144 samples, 11 amplicons (4 topoisomerase
and 7 MLST amplicons) were pooled in an equimolar ratio
to generate one single sample and sent to the laboratories
of the Institute of Applied Biotechnologies (Prague, Czech
Republic) for sequencing. DNA libraries were constructed using
the Nextera XT DNA Sample Preparation Kit (Illumina, Inc., San
Diego, CA) and twomultiplex sequencing assays (1× 96 samples,
1× 48 samples) were performed on the Illumina MiSeq platform
(Illumina, Inc. San Diego, CA).
NGS Data Analysis
A quality control check of pair-end FASTQ files was performed
as a first step. Bases with Phred Quality Score lower than defined
threshold (threshold = 30) were filtered out. Quality control
included check for possible adapter contamination. Then all
variants of reference sequences of single housekeeping genes
of E. coli (adk, fumC, gyrB, icd, mdh, purA, recA) in FASTA
file were downloaded (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli)
and indexed by Burrows-Wheeler Aligner (BWA version 0.7.13;
Li and Durbin, 2010). Paired-end FASTQ files were aligned
against all indexed reference FASTA files using BWA-mem
algorithm with minimum seed length = 19, matching score = 1,
mismatch penalty = 4, gap open penalty = 6, and gap extension
penalty = 1. Generated Sequence Alignment Map (SAM format)
was converted into its binary form (BAM format) and sorted
by coordinates. Unmapped sequences reads were filtered out
from BAM files. Algorithms Samtools (samtools version 0.1.18)
and VarScan (Koboldt et al., 2009) were applied for variant
calling using the following parameters: minimum coverage =
10, minimum mapping quality = 10, minimum reads = 2,
minimum variant frequency = 0.05, and p = 0.05 were used for
variant calling. Generated Variant Calling Format (VCF format)
was statistically analyzed and a minimum number of variants
(required 0, this number means that our FASTQ files have
100% match with a variant of the reference gene) was evaluated
like a gene form of selected housekeeping gene of E. coli. All
bioinformatics analyses were performed on Operating System
Linux (Ubuntu 14.04 LTS) and using programming language
Python.
Single point mutations in selected part of gyrA, gyrB, parC
and parE including QRDRs were evaluated using the Integrative
Genomics Viewer IGV version 2.3. (Broad Institute, Cambrige,
UK) (https://www.broadinstitute.org/software/igv). The genome
sequence E. coli MG1655 (NC_000913.2) was selected as a
reference sequence for alignment.
Sanger sequencing was performed with 11 samples to confirm
the results of MLST analysis carried out by NGS. This was
done because some problems occurred in the assignment
of the appropriate allele in MLST analysis. Gene sequences
were subsequently submitted to the E. coli MLST Database,
University of Warwick (http://mlst.warwick.ac.uk/mlst/dbs/
Ecoli/). Obtained MLST allele sequences were compared with
the results generated by NGS.
Pulsed-Field Gel Electrophoresis
E. coli isolates belonging to the same sequence type (ST)
according to MLST analysis and originating from different
sources (human, animal or wastewater) were subjected to
examination of their epidemiological relationship using pulsed-
field gel electrophoresis (PFGE). The total genomic DNA
was isolated from overnight bacterial culture according to
the procedure published (Husickova et al., 2012). All samples
were digested with XbaI (30 U for 3 h) (Takara, Bio, Otsu,
Shiga, Japan) and subjected to PFGE. The resulting restriction
profiles were analyzed with the GelCompar II software (Applied
Maths, Kortrijk, Belgium) using the Dice coefficient (1,5%)
for comparing similarity and unweighted pair group method
using arithmetic averages for cluster analysis. The results were
interpreted according to criteria described by Tenover et al.
(1995).
RESULTS
PMQR Genes in E. coli Isolates with
Reduced Susceptibility or Resistance to
Ciprofloxacin
A collection of 1050 isolates of E. coli with reduced susceptibility
or resistance to ciprofloxacin was obtained from humans, food
producing, or wild animals and wastewater samples from the
area of the Olomouc and South Moravian Regions, Czech
Republic (Table 1). The highest occurrence of E. coli strains
isolated from MCACIP of animal originwas detected from
turkey samples (105 isolates per 120 samples), the lowest from
chicken samples (156 isolates per 2628 samples). In human
population, 303 E. coli isolates were selected according to the
procedure described in material and methods section. From the
total amount of 124 wastewater samples, 372 E. coli isolates
were analyzed.
PMQR genes were identified in 262 (25%) E. coli isolates
(Table 1). The gene qnrS1 was the most prevalent, found in 56%
of PMQR-positive isolates from all studied areas. It was identified
in 76% PMQR-positive isolates from poultry farms, turkey, rooks
and wastewater. The second most common gene was aac(6′)-
Ib-cr found in 82% of human PMQR-positive clinical isolates
followed by qnrB19 that dominated in isolates from turkey and
wastewater samples. The qnrA, qnrC, and qepA genes were not
found.
Twenty-three isolates carried two different PMQR genes
of the following combination: qnrB19+qnrS1 (12 isolates),
qnrB1+aac(6′)-Ib-cr (7), qnrB4+aac(6′)-Ib-cr (2), qnrS1+oqxAB
(1) qnrB10+qnrS1 (1).
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In case of wastewaters where more than one E. coli colony per
sample was examined, the occurrence of several E. coli isolates
carrying different PMQR genes and originating the same water
sample was detected. Six wastewater samples contained E. coli
isolates carrying qnrS1 together with E. coli carrying qnrB19were
detected. In one sample E. coli harboring qnrB1 and E. coli with
qnrS1 were found. The last sample contained two different types
of E. coli, one carrying aac(6′)-Ib-cr and the other with qnrS1.
Antimicrobial Susceptibility of
PMQR-Positive Isolates
For each PMQR-positive E. coli isolate, susceptibility to 23
antimicrobial agents was tested (Table S2). Isolates from
hospitalized patients showed the highest level of resistance
including ampicillin (97%), piperacillin (96%), third generation
cephalosporins (63% for cefotaxime and 43% for ceftazidime),
tetracycline (83%), and tobramycin (86%). Isolates from the
community displayed high level of resistance to ampicillin
(93%), tetracycline (93%), piperacillin (93%), tobramycin (64%),
and resistance to third generation cephalosporins (50.0% for
cefotaxime and 43% for ceftazidime). On the other hand,
wastewater isolates were less resistant to tested antibiotics.
High level of resistance was detected only for ampicillin (79%),
tetracycline (83%) and piperacillin (78%).
Resistance to ampicillin was common also among isolates
from retailed turkeys (96%), chicken farms (71%) and rook
feces (75%). Other frequent resistance phenotypes included
tetracycline and piperacillin found in 77 and 59% of chicken, in
86 and 90% from turkey and in 75 and 70% from rook isolates,
respectively. The majority of E. coli isolates from food-producing
animals were susceptible to third generation cephalosporins
while 20% of rook isolates showed resistance. Most isolates
from the inpatients and the community showed resistance to
ciprofloxacin. A total of 270 isolates were resistant (MIC of
ciprofloxacin >0.5 mg/L) and 33 sensitive (MIC of ciprofloxacin
≤0.5 mg/L) according to the EUCAST criteria. However, this
results is influenced by different selection criteria for human
isolates since isolates with MIC of ciprofloxacin >0.5 mg/L
were preferably included in the study. In contrast, only 50 of
all PMQR-positive isolates from other studied areas showed
resistance to ciprofloxacin with the highest level observed in
isolates from chicken farms (41%). A total of 36% of animal E. coli
isolates (chicken, turkey, and rook) were resistant to oxolinic
acid, 32% to ofloxacin and 28% to ciprofloxacin. In the group
of wastewater samples, 28% of isolates displayed resistance to
oxolinic acid as well as to ciprofloxacin, and 34% to ofloxacin.
The distribution of MIC values of tested quinolones in selected
isolates (n = 144) and the comparison with the results of genetic
detection is summarized in the Table 2.
A total number of 66 isolates was screened for ESBLs
using phenotypic and genetic methods. Production of ESBL
enzymes was found in 61 E. coli isolates. Subsequent genetic
analysis revealed the presence of blaCTX-M-15 in 51 isolates
(hospital, community, wastewater). Two isolates from chicken
and wastewater carried the gene blaCTX-M-1, blaCTX-M-14 was
found in two isolates from hospital and wastewater and blaSHV-12
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was detected in three isolates from wastewater. Three isolates
showing ESBL phenotype were negative for all tested bla genes.
Mutations in the Topoisomerase Genes in
PMQR-Positive Isolates
Various mutations in gyrA, parC or parE genes were found in 60
out of 144 PMQR-positive isolates while no isolate with mutation
in gyrB was observed (Table 2).
The most common GyrA substitution was Ser(83)Leu found
in 59 isolates (41%), followed by Asp(87)Asn, detected in 49
isolates (34%). A total of 49 isolates carried double or triple
substitution in GyrA.
Two aminoacid substitutions in ParCwere found in 25 isolates
(17%) with Ser(80)Ile and Glu(84)Val being the most common
combination (n = 23). The most common substitution in ParE
was Asp(475)Glu found in 18 isolates (13%).
All the E. coli isolates with a high level of ciprofloxacin
resistance (>32 mg/L) were shown to carry double mutations
in gyrA in combination with single or double mutations in
parC. Substitutions at codon 83 and 87 in GyrA along with
substitutions at codon 80 and 84 in parC gene were the most
common. One isolate carried three mutations in gyrA with
aminoacid changes at positions 83, 84, and 87. The majority
of high-level ciprofloxacin resistant isolates were obtained from
hospitalized patients and possessed the gene aac(6′)-Ib-cr. Other
isolates with high level ciprofloxacin resistance originated from
community and WWTP3 also carried aac(6′)-Ib-cr.
In most isolates susceptible to ciprofloxacin according to
the EUCAST criteria (≤0.5 mg/L), no mutations in gyrA, gyrB,
or parC were detected. However, five isolates possessed single
aminoacid substitution at the codon 83 in GyrA (MIC of
ciprofloxacin was 0.5 mg/L). All isolates were susceptible to
almost all tested antimicrobial agents except ofloxacin (the MIC
was 16–64 mg/L) and three of them were resistant to ofloxacin
(MIC= 2 mg/L). Substitutions at position 378 [Arg(378)His)] or
475 [Asp(475) Glu] in ParE were found in 18 isolates susceptible
to ciprofloxacin (MIC of ciprofloxacin was 0.2 or 0.5 mg/L).
These strains displayed high level of resistance to ampicillin and
piperacillin.
Clonal Relationship of PMQR-Positive
Isolates
In the group of 144 isolates, analyzed by MLST, 48 different
STs were identified (Table S3) including five major clones ST131
(n = 26), ST355 (19), ST48 (13), ST95 (10), and ST10 (5).
Isolates of ST131 were obtained from various types of human
clinical materials and from one wastewater sample, while the
second most common clone ST355 carrying the qnrS1 or the
combination of qnrS1+qnrB19 genes was found predominantly
from retailed turkey. MLST analysis also showed the presence
of identical STs in samples of different origin. Isolates of ST88
or ST226 were identified from chicken farms as well as from
retailed turkeys. ST10, ST48, and ST95 were found in the poultry
and wildlife (chicken farms, retailed turkey, and rooks) and in
wastewater samples. Other sequence types identified in samples
of different origin included ST428, ST533, and ST617. The
determination of relevant ST failed in four samples. In these
samples bioinformatics analysis did not assign appropriate
allele variant and Sanger sequencing did not provide relevant
sequences, suggesting the isolates belonged to atypical E. coli
isolates untypable by MLST.
ST131 was most often associated with blaCTX-M-15 and
aac(6′)-Ib-cr, however one strain harbored the combination of
blaCTX-M-15 a qnrB1. The production of CTX-M-15 enzyme
was also detected together with qnrB1 in one ST393 and two
ST410 strains. In three ST405 and one ST617 a combination of
blaCTX-M-15 and aac(6′)-Ib-cr was identified. One ST48 E. coli
isolate harbored blaCTX-M-15, together with qnrB1 and aac(6′)-
Ib-cr. In one qnrS1-postitive ST43 strain, blaCTX-M-1 gene was
detected. Two qnrS1-positive and SHV-12 producing strains,
one belonging to ST540 and the other to ST58 were identified.
The other CTX-M-14 or CTX-M-15 producing strains were not
analyzed using MLST.
E. coli isolates belonging to the same ST and originating
from different sources (human, animal or environmental) were
subjected to PFGE to determine the level of their genetic
relatedness (Figure 1). Based on these criteria a total of 68 isolates
of the following STs were analyzed: ST10 (n = 5), ST48 (n = 13),
ST58 (n = 2), ST88 (n = 3), ST95 (n = 10), ST131 (n = 26),
ST226 (n= 2), ST428 (n= 2), ST533 (n= 2), and ST617 (n= 3).
Overall, a high diversity of restriction patterns was observed
in isolates of the same ST. No isolates with 100% identity of
PFGE profiles originating from different areas (human, animal,
or environment) were identified.
Globally disseminated ST131 was predominant in samples
from hospitalized patients as well as from community subjects
while no isolates of this clonal group were found in food-
producing animals or rooks. The majority (69%) of E. coli ST131
isolates collected from these samples displayed high-level of
ciprofloxacin resistance (>32mg/L), harbored double or triple
mutations in gyrA along with double mutations in parC gene
and the PMQR gene aac(6′)-Ib-cr. The overall similarity of PFGE
patterns of ST131 isolates was <50% confirming high genetic
diversity of this clonal group. Only two E. coli ST131 isolates
originating from the same patient from which the samples were
taken 17 days apart shared 100% identity.
Significant clonal similarity was detected only in isolates
originating from single collection areas, including ST10, ST48,
ST88, and ST95 from retailed turkeys. In the ST10 group two
isolates shared 100% similarity of their PFGE profiles. Both
isolates were susceptible to ciprofloxacin, carried qnrS1, and did
not contain gyrase or topoisomerase mutations. A group of six
closely related strains was detected in ST48 group. All of them
were collected from turkeys, displayed susceptibility or a low level
of resistance to ciprofloxacin (MIC 1 - 2 mg/L), harbored qnrS1
and were originated from the same turkey farm. Another three
ST48 isolates from WWTP5 displayed 100% identity of their
PFGE patterns, originated from wastewater samples obtained
from the same collection date and shared only 52% similarity of
the PFGE patterns with ST48 isolates from turkey.
In the ST95 group, two and three strains from turkeys showed
identical PFGE profiles. All isolates of the ST95 group were
susceptible to ciprofloxacin, did not possess any mutations in
gyrase or topoisomerase genes and most of them carried both
qnrB19 and qnrS1 genes.
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FIGURE 1 | Dendrogram of E. coli isolates including information about origin, PMQR genes, gyrase and topoisomerase substitutions, MIC of
ciprofloxacin and beta-lactamases.
DISCUSSION
Quinolones are antimicrobial agents widely used in hospitals,
community and veterinary practice. According to the combined
data of ECDC, EFSA, EMA (ECDC, EFSA, and EMA, 2015),
the consumption rate of fluoroquinolones reached 3.2 tons in
primary care sector in the Czech Republic in 2012. The same
data reported that 1.2 tons of fluoroquinolones were used in food
producing animals in the country. However, the consumption of
this class of antibiotics is still relatively low compared to other
countries such as Germany, France, or Italy (ECDC, EFSA, and
EMA, 2015).
The first aim of this study was to investigate the occurrence
of E. coli isolates with PMQR genes in humans, food-producing
animals, wild animals and wastewater samples from a defined
area of the Czech Republic. The results pointed at 25%
occurrence of E. coli with PMQR genes in all areas studied.
The most common PMQR gene in E. coli from humans was
aac(6′)-Ib-cr found mainly in ST131 clone with a high level
of fluoroquinolone resistance. It has been demonstrated that
aac(6′)-Ib-cr gene is more prevalent in E. coli ST131 than other
PMQR genes (Cerquetti et al., 2009; Peirano et al., 2010; Hussain
et al., 2012) and it is carriedmainly by plasmids of incompatibility
group F (IncF) along with genes encoding extended-spectrum
beta-lactamase CTX-M or resistance to other antimicrobial
classes (Woodford et al., 2009; Nicolas-Chanoine et al., 2014).
Regarding other types of PMQR determinants, qnrS1 gene
was identified in all areas examined. It was found (alone or
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in combination with qnrB19) in 73% of isolates that showed
reduced susceptibility to ciprofloxacin and originated from
wastewater samples or food-producing animals. Currently, this
PMQR variant seems widespread in E. coli isolates from various
types of food-producing animals in Europe (Forcella et al., 2010;
Veldman et al., 2011). The second most common qnr variant,
qnrB19, was found predominantly in the isolates from turkeys
and wastewater samples. Both qnrB19 and qnrS1 were previously
detected in chicken broilers in the Czech Republic (Literak et al.,
2013). In E. coli isolates from rooks, qnrB19, qnrD1, qnrS1 and
aac(6′)-Ib-cr were identified. These PMQR variants have been
previously detected in E. coli from rooks sampled in several
European countries including the Czech Republic (Literak et al.,
2012; Jamborova et al., 2015).
All E. coli isolates with high levels of ciprofloxacin resistance
(MIC >32 mg/L), including ST131 clone, carried double or
triple mutations in gyrA in combination with single or double
mutations in parC. E. coli ST131 with specific substitutions
in GyrA or ParC as found in our study have been previously
described (Cerquetti et al., 2010; Platell et al., 2011; Paltansing
et al., 2013). Isolates from poultry and rooks that displayed
clinical levels of ciprofloxacin resistance linked to single or
double mutations in gyrA and parC were found in our study.
Strains of various animal origin with these types of mutations
have been recently found worldwide (Sáenz et al., 2003; Liu et al.,
2012; Castillo et al., 2013; Johnning et al., 2015; Balakrishnan
et al., 2016).
ST131 was the predominant clone in our study found in
the hospitalized patients as well as in the community subjects
and also in one sample from the hospital WWTP. E. coli
ST131 is a worldwide multidrug resistant clone responsible
mainly for urinary but also for other types of infections
and widely disseminated in hospital and community patients
worldwide (Johnson et al., 2003; Cerquetti et al., 2010; Lee
et al., 2010; Nicolas-Chanoine et al., 2014). In the Czech
Republic, isolates of this ST producing CTX-M beta-lactamases
were found in patients suffering from community or hospital
acquired infections (Dolejska et al., 2012; Micenková et al.,
2014; Papagiannitsis et al., 2015). Our results also pointed at
the occurrence of CTX-M-15-producing ST131 clone in UHO.
The ST131 clone has also been isolated from wildlife, companion
animals, and retail chicken meat (Ewers et al., 2010; Ghodousi
et al, 2016; Oh et al., 2016) as well as from wastewater or water
samples (Dolejska et al., 2011a; Colomer-Lluch et al., 2013; Varela
et al., 2015).
ST10 clonal complex (including ST10, ST34, ST43, ST48,
ST167, and ST617) was the second most widespread in our
study. It represents one of the largest clonal complexes within the
E. coliMLST database, generally being antimicrobial-susceptible,
with low virulence (Manges and Johnson, 2012) but it has also
been associated with strains producing ESBL or AmpC beta-
lactamases (Alcalá et al., 2016; Ben Said et al., 2016; Wang et al.,
2016). Based on our results, one ST48 E. coli producing CTX-
M-15 from wastewater, one ST617 strain with CTX-M-15 from
wound swab and one ST43 E. coli with production of CTX-
M-1 beta-lactamase from chicken were identified. In contrast
to other studies (Huijbers et al., 2014; Agabou et al., 2016), no
epidemiological link between human and animal isolates of this
clonal group was observed in our study.
ST95 was the third largest clonal group in our study including
isolates from cloacal swabs from market-weight turkeys and one
isolate from a wastewater sample. This clone has been associated
with infections in domestic (Mora et al., 2013) and wild birds
(Jamborova et al., 2015) as well as urinary tract infections in
humans (Riley, 2014). In contrast to ST131, ST95 lineage includes
less multidrug resistant strains (Gibreel et al., 2012; Adams-
Sapper et al., 2013). ST355 prevalent in our samples frommarket-
weight turkey, seems to be not as widespread in the world
as previous ones. It has been documented in E. coli isolates
from urine and rectal samples in a multinational report by
Adler et al. (2014) and in a study from the U.S. (Tartof et al.,
2007).
Several authors suggested potential transmission of E.
coli clones from animals to humans (Platell et al., 2011;
Agabou et al., 2016; Nüesch-Inderbinen and Stephan, 2016)
and the role of contaminated food in the local spread of
resistant E. coli strains (Vincent et al., 2010). In a study
from Platell et al. (2011), a high level of relatedness of E.
coli ST131 strains from companion animals and humans was
observed. Moreover, Agabou et al. (2016) demonstrated a
clonal relationship between human and chicken ciprofloxacin-
resistant E. coli isolates in North-Eastern Algeria. In contrast
to these studies, we did not find any correlation between
samples of human, animal, or environmental origin. No strains
sharing 100% relatedness and originating from different areas
of collection were identified using PFGE. However, some
limitations of our study might affect the final results. These
include the preferable selection of E. coli isolates resistant to
ciprofloxacin from clinical materials of hospitalized patients
and community subjects, the preferable selection of urine
samples and the absence of rectal samples from a healthy
population.
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